Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for PEGylated Protein Therapeutics
The 2025-2030 World Outlook for PEGylated Protein Therapeutics This study covers the world outlook for PEGylated protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Diabetes Therapeutics
The 2025-2030 World Outlook for Diabetes Therapeutics This study covers the world outlook for diabetes therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Diabetes Therapeutics and Diagnostics
The 2025-2030 World Outlook for Diabetes Therapeutics and Diagnostics This study covers the world outlook for diabetes therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Sarcoma Drugs
The 2025-2030 World Outlook for Sarcoma Drugs This study covers the world outlook for sarcoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More
-
The 2025-2030 World Outlook for Chronic Disease Management Therapeutics and Device Technologies
The 2025-2030 World Outlook for Chronic Disease Management Therapeutics and Device Technologies This study covers the world outlook for chronic disease management therapeutics and device technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More
-
The 2025-2030 World Outlook for Chlamydia Infection Diagnostics and Therapeutics
The 2025-2030 World Outlook for Chlamydia Infection Diagnostics and Therapeutics This study covers the world outlook for chlamydia infection diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema C1 Esterase Inhibitors
The 2025-2030 World Outlook for Hereditary Angioedema C1 Esterase Inhibitors This study covers the world outlook for hereditary angioedema C1 esterase inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for HPV and CMV Therapeutics
The 2025-2030 World Outlook for HPV and CMV Therapeutics This study covers the world outlook for HPV and CMV therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Treatments
The 2025-2030 World Outlook for Multiple Sclerosis Treatments This study covers the world outlook for multiple sclerosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Pharmaceuticals for Women's Health
The 2025-2030 World Outlook for Pharmaceuticals for Women's Health This study covers the world outlook for pharmaceuticals for women's health across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Retinal Disease Therapeutics
The 2025-2030 World Outlook for Retinal Disease Therapeutics This study covers the world outlook for retinal disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Hereditary Angioedema Therapeutics
The 2025-2030 World Outlook for Hereditary Angioedema Therapeutics This study covers the world outlook for hereditary angioedema therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Acromegaly
The 2025-2030 World Outlook for Acromegaly This study covers the world outlook for acromegaly across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Myelodysplastic Syndrome Drugs
The 2025-2030 World Outlook for Myelodysplastic Syndrome Drugs This study covers the world outlook for myelodysplastic syndrome drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Human Growth Hormone Drugs
The 2025-2030 World Outlook for Subcutaneous Human Growth Hormone Drugs This study covers the world outlook for subcutaneous human growth hormone drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Angina Pectoris Antiplatelet Drugs
The 2025-2030 World Outlook for Angina Pectoris Antiplatelet Drugs This study covers the world outlook for angina pectoris antiplatelet drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Compound Management Instruments
The 2025-2030 World Outlook for Compound Management Instruments This study covers the world outlook for compound management instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Gastrointestinal Therapeutics
The 2025-2030 World Outlook for Gastrointestinal Therapeutics This study covers the world outlook for gastrointestinal therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Animal Therapeutics and Diagnostics
The 2025-2030 World Outlook for Animal Therapeutics and Diagnostics This study covers the world outlook for animal therapeutics and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Menopausal Hot Flashes Therapies
The 2025-2030 World Outlook for Menopausal Hot Flashes Therapies This study covers the world outlook for menopausal hot flashes therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Topical Drugs for Hyperpigmentation Disorders Treatments
The 2025-2030 World Outlook for Topical Drugs for Hyperpigmentation Disorders Treatments This study covers the world outlook for topical drugs for hyperpigmentation disorders treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
-
The 2025-2030 World Outlook for Small Molecule Therapies for Rheumatoid Arthritis
The 2025-2030 World Outlook for Small Molecule Therapies for Rheumatoid Arthritis This study covers the world outlook for small molecule therapies for rheumatoid arthritis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2025-2030 World Outlook for Anemia Drugs
The 2025-2030 World Outlook for Anemia Drugs This study covers the world outlook for anemia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the ... Read More
-
The 2025-2030 World Outlook for Tinea Pedis (Athlete's Foot) Drugs
The 2025-2030 World Outlook for Tinea Pedis (Athlete's Foot) Drugs This study covers the world outlook for tinea pedis (athlete's foot) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Genital Herpes Treatments
The 2025-2030 World Outlook for Genital Herpes Treatments This study covers the world outlook for genital herpes treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
Research Assistance
